Losartan Potassium
Product Images NDC 53002-2638
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Losartan Potassium (NDC 53002-2638). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Rpk Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Losartan Fig1
This text seems to be a chart or a graph related to a study involving the medications Atenolol and Losartan Potassium. The graph displays a line plot for a period of 66 months with different time intervals on the x-axis. The y-axis has text that says, "Adjusted Risk Reduction: 13%, p=" which suggests that the plot is representing the effect of the medications on reducing risk. However, the plot or graph is incomplete, and it is not possible to infer any accurate conclusion from this text.*
Losartan Fig2
Figure 3 (Losartan Fig3)
Figure-4 (Losartan Fig4)
This appears to be a summary of a clinical trial comparing a drug called Losttan Potassium to a placebo. The table shows the percentage of patients who experienced an event (not specified) with Losttan Potassium and the placebo, as well as the risk reduction and p-value for the drug. Since there is no additional information, it is not possible to provide a more detailed description or analysis.*
Chemical Structure (Losartan Str)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.